ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding ADC Therapeutics SA changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 56 | 53 | −3 |
| Shares | 33.5M | 32.8M | −740.5K (−2.2%) |
| Value | $816.3M | $890.6M | +$74.4M (+9.1%) |
New holders (7)
Institutions that held ADC Therapeutics SA at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 1,111,901 | $30.2M | 0.03% |
| Man Group plc | 19,813 | $538.0K | 0.00% |
| Snowden Capital Advisors LLC | 14,323 | $389.0K | 0.02% |
| Dark Forest Capital Management LP | 923 | $25.0K | 0.01% |
| Deutsche Bank AG | 300 | $8.00K | 0.00% |
| Focused Wealth Management, Inc | 300 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 45 | $1.00K | 0.00% |
Sold out (10)
Institutions that held ADC Therapeutics SA at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Baker Bros. Advisors LP | 1,418,107 | $34.5M |
| Burrage Capital Management LLC | 124,875 | $3.04M |
| Caption Management, LLC | 42,500 | $1.03M |
| Susquehanna International Group, LLP | 32,124 | $782.0K |
| PEAK6 Investments LLC | 31,912 | $777.0K |
| AlphaCentric Advisors LLC | 26,000 | $633.0K |
| FORA Capital, LLC | 1,089 | $27.0K |
| Sandy Spring Bank | 1,000 | $24.0K |
| Group One Trading, L.P. | 200 | $5.00K |
| UBS Group AG | 157 | $4.00K |